PRCTProcept BioRobotics Corp
PRCT
Procept BioRobotics Corp1,277
Mkt Cap
$1.37BVolume
386,050.0052W High
$66.8552W Low
$19.35PE Ratio
-13.14PRCT Fundamentals
Price
$23.91Prev Close
$24.04Open
$23.6850D MA
$25.22Beta
1.17Avg. Volume
1.81MEPS (Annual)
-$1.72P/B
3.70Rev/Employee
$346,907.66$1,539.39
Poll
Earnings Recap
• Reported GAAP EPS of -$0.56 down -24.44% YoY • Reported revenue of $83.13M up 20.20% YoY • Procept BioRobotics expects full year 2026 revenue of $390 million to $410 million, representing 27% to 33% growth, with gross margin around 65% and an adjusted EBITDA loss between $17 million and $30 million.
Bullish
Procept BioRobotics achieved 20% revenue growth to $83.1 million and 30% U.S. procedure growth, alongside gross margin expansion and FDA clearance for its FirstAssist AI software.
Bearish
Procept BioRobotics reported an increased net loss and adjusted EBITDA loss, coupled with higher operating expenses and near-term disruption from commercial realignment.